Savvy Advisors, Inc. Agios Pharmaceuticals, Inc. Transaction History
Savvy Advisors, Inc.
- $2.09 Billion
- Q3 2025
A detailed history of Savvy Advisors, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Savvy Advisors, Inc. holds 11,993 shares of AGIO stock, worth $523,494. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,993
Previous 21,781
44.94%
Holding current value
$523,494
Previous $724,000
33.56%
% of portfolio
0.02%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
258Shares Held
63.8MCall Options Held
2.06MPut Options Held
911K-
Farallon Capital Management LLC San Francisco, CA5.78MShares$252 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$245 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$212 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.71MShares$162 Million3.19% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.76MShares$121 Million1.05% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.39B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...